Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Lymphoid 2Dermatologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1CNS 1

Conditions

Mesothelioma, Malignant 46Mesothelioma 40Carcinoma, Non-Small-Cell Lung 13Advanced Solid Tumors 6Unspecified Adult Solid Tumor, Protocol Specific 5Solitary Fibrous Tumor, Pleural 5Advanced Solid Tumor 4Lung Neoplasms 3Solid Tumors 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Lymphoma, Non-Hodgkin 2Breast Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Thymus Neoplasms 1Thymoma 1Solid Tumor Cancer 1Solid Tumor 1Severe combined immunodeficiency with sensitivity to ionizing radiation 1Sarcoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1

Interventions

ruxolitinib 1avelumab 1Pemetrexed 1Imatinib Mesylate 1Fentanyl 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Primary Myelofibrosis × Pemetrexed × Other solid neoplasm × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡